{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:44:01Z","timestamp":1792608241552,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2006,5,24]],"date-time":"2006-05-24T00:00:00Z","timestamp":1148428800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2006,9,14]]},"DOI":"10.1007\/s00259-006-0113-7","type":"journal-article","created":{"date-parts":[[2006,5,24]],"date-time":"2006-05-24T11:10:36Z","timestamp":1148469036000},"page":"1123-1133","source":"Crossref","is-referenced-by-count":75,"title":["99mTc-EDDA\/HYNIC-octreotate scintigraphy, an efficient method for the detection and staging of carcinoid tumours: results of 3\u00a0years\u2019 experience"],"prefix":"10.1007","volume":"33","author":[{"given":"A.","family":"Hubalewska-Dydejczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Fr\u00f6ss-Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Miko\u0142ajczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. R.","family":"Maecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Huszno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Pach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sowa-Staszczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Janota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Szybi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kulig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,5,24]]},"reference":[{"issue":"3","key":"113_CR1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/frne.1999.0183","volume":"20","author":"YC Patel","year":"1999","unstructured":"Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol 1999;20(3):157\u201398","journal-title":"Front Neuroendocrinol"},{"issue":"4","key":"113_CR2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF00169802","volume":"20","author":"DJ Kwekkeboom","year":"1993","unstructured":"Kwekkeboom DJ, Krenning EP, Bakker WH, Oei HY. Somatostatin analogue scintigraphy in carcinoid tumours. Eur J Nucl Med 1993;20(4):283\u201392","journal-title":"Eur J Nucl Med"},{"issue":"8","key":"113_CR3","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/BF00181765","volume":"20","author":"EP Krenning","year":"1993","unstructured":"Krenning EP, Kwekkeboom DJ, Bakker WA, Breeman WA, Kooij PP, Oei HY, et al. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe] and [123I-tyr]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993;20(8):716\u201331","journal-title":"Eur J Nucl Med"},{"issue":"5","key":"113_CR4","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1378\/chest.117.5.1232","volume":"177","author":"J Blum","year":"2000","unstructured":"Blum J, Handmaker H, Lister-James J, Rinne N. A multi-center trial with a somatostatin analog 99mTc depreotide in the evaluation of solitary pulmonary nodules. Chest 2000;177(5):1232\u20138","journal-title":"Chest"},{"issue":"9","key":"113_CR5","first-page":"1850","volume":"58","author":"I Virgolini","year":"1998","unstructured":"Virgolini I, Leimer M, Handmaker H, Lastoria S, Bischof C, Muto P, et al. Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, 99mTc-P829. Cancer Res 1998;58(9):1850\u20139","journal-title":"Cancer Res"},{"key":"113_CR6","first-page":"791","volume":"22","author":"M Behe","year":"1995","unstructured":"Behe M, Maecke HR. New somatostatin analogues labelled with technetium-99m [abstract]. Eur J Nucl Med 1995;22:791","journal-title":"Eur J Nucl Med"},{"issue":"5","key":"113_CR7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1021\/bc970058b","volume":"8","author":"S Liu","year":"1997","unstructured":"Liu S, Edwards DS, Barrett JA. 99mTc labelling of highly potent small peptides. Bioconjugate Chem 1997;8(5):621\u201336","journal-title":"Bioconjugate Chem"},{"issue":"11","key":"113_CR8","first-page":"1964","volume":"34","author":"JW Babich","year":"1993","unstructured":"Babich JW, Solomon H, Pike MC, Kroon D, Graham W, Abrams MJ, et al. Technetium-99m-labelled hydrazino nicotinamid derivatized chemotactic peptide analogues for imaging focal sites of bacterial infection. J Nucl Med 1993;34(11):1964\u201374","journal-title":"J Nucl Med"},{"issue":"6","key":"113_CR9","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s002590050556","volume":"27","author":"M Bangard","year":"2000","unstructured":"Bangard M, Behe M, Guhlke S, Otte R, Bender H, Maecke HR, et al. Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In DTPA-D-Phe1-octreotide. Eur J Nucl Med 2000;27(6):628\u201337","journal-title":"Eur J Nucl Med"},{"issue":"8","key":"113_CR10","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s002590050461","volume":"26","author":"C Decristoforo","year":"1999","unstructured":"Decristoforo C, Mather JS. Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence. Eur J Nucl Med 1999;26(8):869\u201376","journal-title":"Eur J Nucl Med"},{"issue":"9","key":"113_CR11","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/s002590000289","volume":"27","author":"C Decristoforo","year":"2000","unstructured":"Decristoforo C, Mather JS, Cholewinski W, Donnemiller E, Riccabona G, Moncayo R. 99mTc EDDA\/HYNIC-TOC: a new 99m Tc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives. Eur J Nucl Med 2000;27(9):1318\u201325","journal-title":"Eur J Nucl Med"},{"issue":"10","key":"113_CR12","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1007\/s00259-003-1254-6","volume":"30","author":"A P\u0142achci\u0144ska","year":"2003","unstructured":"P\u0142achci\u0144ska A, Miko\u0142ajczak R, Maecke HR, M\u0142odkowska E, Kunert-Radek J, Michalski A, et al. Clinical usefulness of 99mTc EDDA\/HYNIC-TOC scintigraphy in oncological diagnostics: a preliminary communication. Eur J Nucl Med Mol Imaging 2003;30(10):1402\u20136","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"113_CR13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s002590050034","volume":"27","author":"JC Reubi","year":"2000","unstructured":"Reubi JC, Schar JC, Waser B, Wenger S, Heppeler A, Schmitt JS, et al. Affinity profiles for human somatostatin receptor subtypes SST1\u2013SST5 for somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med 2000;27(3):273\u201382","journal-title":"Eur J Nucl Med"},{"issue":"9","key":"113_CR14","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s002590100574","volume":"28","author":"KJ Kwekkeboom","year":"2001","unstructured":"Kwekkeboom KJ, Bakker WH, Kooij PP, Konijnenberg MW, Srinivasan A, Erion L, et al. [177Lu-DOTA0,Tyr3] octreotate: comparison with [111In-DTPA0]octreotide in patients. Eur J Nucl Med 2001;28(9):1319\u201325","journal-title":"Eur J Nucl Med"},{"issue":"9","key":"113_CR15","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00259-003-1225-y","volume":"30","author":"C Decristoforo","year":"2003","unstructured":"Decristoforo C, Maina T, Nock B, Gabriel M, Cordopatis P, Moncayo R. 99mTc Demotate 1: first data in tumour patients results of a pilot\/phase I study. Eur J Nucl Med Mol Imaging 2003;30(9):1211\u20139","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"113_CR16","doi-asserted-by":"crossref","unstructured":"Solcia E, Kloppel G, Sobin LH, et al. Histologic typing of endocrine tumours. WHO International Histological Classification of Tumours. Berlin Heidelberg New York: Springer, 2000","DOI":"10.1007\/978-3-642-59655-1"},{"issue":"Suppl 4","key":"113_CR17","first-page":"iv1","volume":"54","author":"JK Ramage","year":"2005","unstructured":"Ramage JK, Davies AH, Ardill J, Bax N, Caplin M, Grossman A, et al. UK NETwork for Neuroendocrine Tumours. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut 2005;54(Suppl 4):iv1\u2013iv16","journal-title":"Gut"},{"issue":"3","key":"113_CR18","first-page":"157","volume":"11","author":"SK Kuwada","year":"2000","unstructured":"Kuwada SK. Carcinoid tumours. Semin Gastrointest Dis 2000;11(3):157\u201361","journal-title":"Semin Gastrointest Dis"},{"issue":"10","key":"113_CR19","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1007\/s002590100600","volume":"28","author":"SA Benjeg\u00e4rd","year":"2001","unstructured":"Benjeg\u00e4rd SA, Forssell-Aronsson E, W\u00e4ngberg B, Sk\u00e4nberg J, Nilsson O, Ahlman H. Intraoperative tumour detection using 111In DTPA-D-Phe-octreotide and scintillation a detector. Eur J Nucl Med 2001;28(10):1456\u201362","journal-title":"Eur J Nucl Med"},{"issue":"1","key":"113_CR20","first-page":"59","volume":"44","author":"S Adams","year":"2000","unstructured":"Adams S, Baum RP. Intraoperative use of gamma-detecting probes to localize neuroendocrine tumors. Q J Nucl Med 2000;44(1):59\u201367","journal-title":"Q J Nucl Med"},{"issue":"6","key":"113_CR21","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s00259-003-1449-x","volume":"31","author":"W Cholewinski","year":"2004","unstructured":"Cholewinski W, Kowalczyk JR, Stefaniak B, Stefaniak J, Poniatowicz-Frasunek E, Tarkowska A. Diagnosis and staging of children\u2019s lymphoma using the technetium-labelled somatostatin analogue, 99mTc-depreotide. Eur J Nucl Med Mol Imaging 2004;31(6):820\u20134","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"113_CR22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/qjmed\/91.4.295","volume":"91","author":"W Shi","year":"1998","unstructured":"Shi W, Johnston CF, Buchanan KD, Ferguson WR, Laird JD, Crothers JG, McIlrath EM. Localization of neuroendocrine tumours with [111In]DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging. Q J Med 1998;91(4):295\u2013301","journal-title":"Q J Med"},{"issue":"10","key":"113_CR23","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1007\/s002590050314","volume":"25","author":"A Chiti","year":"1998","unstructured":"Chiti A, Fanti S, Savelli G, Romeo A, Bellanova B, Rodari M, et al. Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours. Eur J Nucl Med 1998;25(10):1396\u2013403","journal-title":"Eur J Nucl Med"},{"issue":"9130","key":"113_CR24","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(98)02286-7","volume":"352","author":"ME Caplin","year":"1998","unstructured":"Caplin ME, Buscombe JR, Hilson AJ, Jones AL, Watkinson AF, Burroughs AK. Carcinoid tumour. Lancet 1998;352(9130):799\u2013805","journal-title":"Lancet"},{"issue":"3","key":"113_CR25","first-page":"359","volume":"44","author":"O Schillaci","year":"2003","unstructured":"Schillaci O, Spanu A, Scopinaro F, Falchi A, Danieli R, Marongiu P, et al. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors. J Nucl Med 2003;44(3):359\u201368","journal-title":"J Nucl Med"},{"issue":"8","key":"113_CR26","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/cncr.20939","volume":"15:103","author":"J Soga","year":"2005","unstructured":"Soga J. Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases. Cancer 2005;15:103(8):1587\u2013595","journal-title":"Cancer"},{"key":"113_CR27","unstructured":"Vinik A. Carcinoid tumors. http:\/\/www.endotext.com\/guthormones\/guthormone2\/guthormoneframe2.htm"},{"issue":"2","key":"113_CR28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1634\/theoncologist.10-2-123","volume":"10","author":"JM Zuetenhorst","year":"2005","unstructured":"Zuetenhorst JM, Taal BG. Metastatic carcinoid tumors: a clinical review. Oncologist 2005;10(2):123\u201331","journal-title":"Oncologist"},{"issue":"4","key":"113_CR29","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s002590100490","volume":"28","author":"G Paganelli","year":"2001","unstructured":"Paganelli G, Zoboli S, Cremonesi M, Bodei L, Ferrari M, Grana C, Bartolomei M. Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide. Eur J Nucl Med 2001;28(4):426\u201334","journal-title":"Eur J Nucl Med"},{"issue":"12","key":"113_CR30","first-page":"1856","volume":"42","author":"BJ Fueger","year":"2001","unstructured":"Fueger BJ, Hamilton G, Raderer M, Pangerl T, Traub T, Angelberger P, et al. Effects of chemotherapeutic agents on expression of somatostatin receptors in pancreatic tumor cells. J Nucl Med 2001;42(12):1856\u201362","journal-title":"J Nucl Med"},{"issue":"3","key":"113_CR31","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00259-003-1379-7","volume":"31","author":"H Amthauer","year":"2004","unstructured":"Amthauer H, Ruf J, Bohmig M, Lopez-Hanninen E, Rohlfing T, Wernecke KD, et al. Diagnosis of neuroendocrine tumours by retrospective image fusion: is there a benefit? Eur J Nucl Med Mol Imaging 2004;31(3):342\u20138","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"113_CR32","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s002590100639","volume":"28","author":"M Hofmann","year":"2001","unstructured":"Hofmann M, Maecke H, B\u00f6rner AR, Weckesser E, Sch\u00f6ffski P, Oei L, et al. Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data. Eur J Nucl Med 2001;28(12):1751\u20137","journal-title":"Eur J Nucl Med"},{"issue":"1","key":"113_CR33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1536-1632(03)00038-6","volume":"5","author":"J Kowalski","year":"2003","unstructured":"Kowalski J, Henze M, Schuhmacher J, Macke HR, Hofmann M, Haberkorn U. Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe1-Tyr3-octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors. Mol Imaging Biol 2003;5(1):42\u20138","journal-title":"Mol Imaging Biol"},{"issue":"2","key":"113_CR34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.beem.2004.11.016","volume":"19","author":"K \u00d6berg","year":"2005","unstructured":"\u00d6berg K, Eriksson B. Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours. Best Pract Res Clin Endocrinol Metab 2005;19(2):265\u201376","journal-title":"Best Pract Res Clin Endocrinol Metab"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-006-0113-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-006-0113-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-006-0113-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T15:58:54Z","timestamp":1558713534000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-006-0113-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,24]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,9,14]]}},"alternative-id":["113"],"URL":"https:\/\/doi.org\/10.1007\/s00259-006-0113-7","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,24]]}}}